Following the results of the CRASH 3 trial, TXA should be administered to any patient aged 18 years and over who have a known or suspected head injury, with a GCS of 12 or less, where the injury has occurred within the last 3 hours.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.